V. A. Nesmeyanov

556 citations

43 papers · 441 indexed · h-index 10

Co-authors: S. E. ZURABYAN A. Ya. Khorlin Ekaterina Dementieva A. Yu. Rubina E. V. Grishin А. С. Заседателев Elena Arystarkhova Yu.A. Ovchinnikov
Topics: Monoclonal and Polyclonal Antibodies Research (15 papers)Glycosylation and Glycoproteins Research (14 papers)Antimicrobial Peptides and Activities (7 papers)
Cited by: Microbiology Immunology Biotechnology
Journals: Analytical Biochemistry FEBS Letters Protein Science
Partner nations: Russia United States Finland

In The Last Decade

V. A. Nesmeyanov

43 papers receiving 416 citations

Peers

Countries citing papers authored by V. A. Nesmeyanov

Since Specialization

Citations

This map shows the geographic impact of V. A. Nesmeyanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. A. Nesmeyanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. A. Nesmeyanov more than expected).

Fields of papers citing papers by V. A. Nesmeyanov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. A. Nesmeyanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. A. Nesmeyanov. The network helps show where V. A. Nesmeyanov may publish in the future.

Co-authorship network of co-authors of V. A. Nesmeyanov

This figure shows the co-authorship network connecting the top 25 collaborators of V. A. Nesmeyanov. A scholar is included among the top collaborators of V. A. Nesmeyanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. A. Nesmeyanov. V. A. Nesmeyanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural modification effects on bioactivities of the novel 15-mer peptide adjuvant 2011 ·Vaccine ·(unknown),A. O. Shepelyakovskaya,(unknown),(unknown),(unknown),(unknown),(unknown),Timo Korpela,V. A. Nesmeyanov,Ф. А. Бровко	5
2	A method for the preparation of adjuvant peptide mimetics of GMDP with the use of monoclonal antibodies and combinatorial libraries of peptides in the format of phage display 2010 ·Russian Journal of Bioorganic Chemistry ·(unknown),A. O. Shepelyakovskaya,(unknown),(unknown),Ф. А. Бровко,V. A. Nesmeyanov	1
3	GMDP augments antitumor action of the CP/TNFα combination in vivo 2009 ·Biomedicine & Pharmacotherapy ·(unknown),(unknown),(unknown),(unknown),(unknown),V. A. Nesmeyanov,(unknown)	2
4	Refolding of scFv mini-antibodies using size-exclusion chromatography via arginine solution layer 2009 ·Journal of Chromatography B ·(unknown),(unknown),Bogdan S. Melnik,Gennady V. Semisotnov,(unknown),(unknown),V. A. Nesmeyanov,Ф. А. Бровко	11
5	Glucosaminylmuramyl dipeptide potentiates the effects of tumor necrosis factor-α and cisplatin on transformed cells in vitro 2007 ·Bulletin of Experimental Biology and Medicine ·(unknown),(unknown),(unknown),(unknown),V. A. Nesmeyanov	4
6	Muramyl peptides augment cytotoxic effect of tumor necrosis factor-alpha in combination with cytotoxic drugs on tumor cells 2006 ·International Immunopharmacology ·(unknown),(unknown),(unknown),(unknown),С. В. Хайдуков,(unknown),(unknown),(unknown),(unknown),V. A. Nesmeyanov	7
7	Identification of pentadecapeptide mimicking muramyl peptide 2006 ·Vaccine ·(unknown),A. O. Shepelyakovskaya,Igor Berezin,(unknown),(unknown),(unknown),(unknown),Ф. А. Бровко,(unknown),(unknown),V. A. Nesmeyanov	9
8	The Library of Human Miniantibodies in the Phage Display Format: Designing and Testing 2005 ·Doklady Biochemistry and Biophysics ·(unknown),(unknown),(unknown),A. O. Shepelyakovskaya,(unknown),(unknown),(unknown),(unknown),Ф. А. Бровко,V. A. Nesmeyanov	7
9	Quantitative immunoassay of biotoxins on hydrogel-based protein microchips 2005 ·Analytical Biochemistry ·A. Yu. Rubina,(unknown),Ekaterina Dementieva,(unknown),V. A. Nesmeyanov,E. V. Grishin,А. С. Заседателев	71
10	The Production of Miniantibodies Against Human Granulocyte Colony-Stimulating Factor Using the Murine scFv Combinatory Library 2002 ·Russian Journal of Bioorganic Chemistry ·(unknown),A. O. Shepelyakovskaya,(unknown),(unknown),(unknown),(unknown),(unknown),V. A. Nesmeyanov	2
11	Induction of Antimeningitis Immunity by Synthetic Peptides: III. Immunoactive Synthetic Fragments of the NspA Protein from Neisseria meningitidis 2002 ·Russian Journal of Bioorganic Chemistry ·(unknown),(unknown),М. Н. Жмак,(unknown),(unknown),(unknown),(unknown),O. M. Volpina,V. A. Nesmeyanov,(unknown),В. Т. Иванов	1
12	Crystal structure of an anti‐interleukin‐2 monoclonal antibody Fab complexed with an antigenic nonapeptide 2001 ·Protein Science ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Vadim T. Ivanov,(unknown),V. A. Nesmeyanov,(unknown),Walter Pangborn,William L. Duax,В. З. Плетнев	6
13	Destabilase from the medicinal leech is a representative of a novel family of lysozymes 2000 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·(unknown),I. P. Baskova,Sergey Lukyanov,(unknown),E. V. Snezhkov,С. Б. Акопов,Irena I. Artamonova,(unknown),V. A. Nesmeyanov,Д. Г. Козлов,(unknown),Valentina I. Kiseleva,A.M. Poverenny,E. D. Sverdlov	75
14	Specific binding of glucosaminylmuramyl peptides to histones 1999 ·FEBS Letters ·(unknown),(unknown),Kristine M. Swiderek,(unknown),Nikolai V. Bovin,John E. Shively,V. A. Nesmeyanov	6
15	Endogenous tumour necrosis factor‐alpha sensitise melanoma cells to glucosaminylmuramyl dipeptide 1998 ·FEBS Letters ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),V. A. Nesmeyanov	4
16	Immunoregulatory properties of hexapeptide isolated from porcine bone marrow cell culture 1994 ·Regulatory Peptides ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),V. A. Nesmeyanov,Petrov Rv	15
17	Biochemical characterization of glucosaminylmuramyldipeptide binding sites of murine macrophages 1994 ·FEBS Letters ·(unknown),Marina Sumaroka,(unknown),(unknown),(unknown),V. A. Nesmeyanov	8
18	Muramyl peptide‐binding sites are located inside target cells 1991 ·FEBS Letters ·Marina Sumaroka,(unknown),С. В. Хайдуков,(unknown),(unknown),(unknown),(unknown),(unknown),V. A. Nesmeyanov,В. Т. Иванов	17
19	Immunostimulatory factors produced by nonstimulated lymphocytes 1988 ·Immunologiya ·(unknown),Tatiana N. Golovina,(unknown),V. A. Nesmeyanov	1
20	Production of interleukin 2 in serum-free medium 1984 ·Molecular Immunology ·(unknown),(unknown),(unknown),V. A. Nesmeyanov	5

About V. A. Nesmeyanov

V. A. Nesmeyanov is a scholar working on Microbiology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 43 papers that have together received 441 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (14 papers) and Antimicrobial Peptides and Activities (7 papers). The work is most often cited by research in Microbiology (42 citations), Immunology (112 citations) and Biotechnology (39 citations). V. A. Nesmeyanov has collaborated with scholars based in Russia, United States and Finland. Frequent co-authors include S. E. ZURABYAN, A. Ya. Khorlin, Ekaterina Dementieva, A. Yu. Rubina, E. V. Grishin, А. С. Заседателев, Elena Arystarkhova, Yu.A. Ovchinnikov, Alexander Kozhich and N.N. Modyanov. Their work appears in journals such as Analytical Biochemistry, FEBS Letters and Protein Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact